Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
We have shown that measurement of anti-CD38 IgG antibodies in plasma or in peripheral blood mononuclear cells (including lymphocytes T) is applicable to diagnosis and prognosis of systemic lupus erythematosus More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Related Reports
Market Research Reports provided by reports.innovaro.com
Mar 2011 - 5 pages - $500
Mar 2011 - 34 pages - $5,700
Jan 2008 - 180 pages - $3,500
May 2011 - 15 pages - $250
Aug 2007 - 345 pages - $2,875
Nov 2010 - 240 pages - $1,495
Mar 2011 - 42 pages - $500
Oct 2011 - 56 pages - $500
Dec 2010 - 37 pages - $500
Aug 2011 - 6 pages - $11,400
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us